Amy DuRoss is a seasoned leader and innovator in precision and personalized medicine, boasting over 25 years of experience in the life sciences, pharma services, and venture capital sectors. Currently, they serve as the CEO and a board director for several companies, including BioLife Solutions and Central Pharma. Previously, Amy co-founded Vineti, leading the company in securing over $150 million in funding and establishing significant partnerships within the biopharmaceutical industry. A dedicated patient advocate, they played a vital role in the creation of California's Proposition 71, which funded $8 billion for stem cell research. Amy holds an MBA from Stanford University and is a Health Innovator Fellow at the Aspen Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices